文献速递临床试验与 GCP基础与转化研究

基于功能临床测试的个体化低成本可及性肺康复方案:COPD患者随机对照试验研究方案

Individualized, low-cost and accessible pulmonary rehabilitation program based on functional clinical tests for individuals with COPD-a study protocol of a randomized controlled trial.
PubMed 文献 · Trials · 2021-05-26

本研究为一项单盲、优效性随机对照试验方案,在巴西圣卡洛斯联邦大学肺功能与呼吸物理治疗实验室开展,样本量50例COPD患者。方案描述一种可及、低成本且个体化的肺康复项目,比较有或无每周物理治疗师监督下训练的效果,预期在运动能力方面获得阳性结果。

要点

  • 方案为单盲、优效性随机对照试验,样本量50例COPD患者。
  • 干预为个体化低成本肺康复,比较有无每周物理治疗师监督的效果。
  • 主要预期结局为运动能力,旨在提供更可及有效的肺康复方案。

核心结论

  • 预期低成本且辅以家庭运动的监督康复项目将呈阳性结果,尤其在运动能力方面。
  • 该方案有望为COPD患者提供更可及且有效的肺康复项目。

研究设计与样本

  • 研究为临床随机对照试验的描述性方案,单盲、优效性设计。
  • 研究在巴西圣卡洛斯联邦大学肺功能与呼吸物理治疗实验室开展。
  • 样本量为50例患者,依据预试验结果计算得出。
  • 试验注册于巴西临床试验注册平台ReBec,注册号UTN U1111-1220-8245。

临床怎么用

  • 方案采用个体化处方并辅以物理治疗师监督,可用于COPD患者肺康复实践参考。
  • 方案强调低成本与可及性,适合在资源有限环境中推广。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Patients with chronic obstructive pulmonary disease (COPD) present pulmonary and extrapulmonary impairments. The strategies used to mitigate these impairments are pulmonary rehabilitation programs (PRP). However, there is limited access to PRP in specialized centers and the study of low-cost home rehabilitation programs had non-individualized prescription, which might have led to insignificant positive effects. So, it is important to develop new low-cost protocols that involve individualized prescription, as well as physiotherapist supervision. This study describes an accessible, low-cost, and individualized pulmonary rehabilitation protocol and compare its results when performed with or without a weekly physiotherapist-supervised session on patients with COPD. METHODS: This is a descriptive protocol of a clinical trial, randomized, single-blinded, and type of framework is superiority conducted at the Spirometry and Respiratory Physical Therapy Laboratory of the Federal University of São Carlos (UFSCar). The trial is registered in the Brazilian Clinical Trials Registry (ReBec) URL: http://www.ensaiosclinicos.gov.br/rg/RBR-533hht/ with Register Number UTN code U1111-1220-8245. The sample size is 50 patients and is calculated using the results of a pilot study. DISCUSSION-POTENTIAL IMPACT AND SIGNIFICANCE OF THE STUDY: It is expected that the low-cost and new supervised rehabilitation program complemented with home exercises will present positive results, especially on exercise capacity, which will make available a more accessible and effective PRP for patients with COPD. TRIAL REGISTRATION: ClinicalTrials.gov U1111-1220-8245 . Registered on September 20, 2018.

来源:Trials,查看原文。版权归原作者所有。

引用

  1. da Silva MMC, Arcuri JF, Di Lorenzo VAP, et al. Individualized, low-cost and accessible pulmonary rehabilitation program based on functional clinical tests for individuals with COPD-a study protocol of a randomized controlled trial. Trials. 2021. PMID: 34039406. doi:10.1186/s13063-021-05267-9

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。